NH-1,2,3-Triazole-based Inhibitors of the VIM-2 Metallo-β-Lactamase: Synthesis and Structure-Activity Studies.

ACS Medicinal Chemistry Letters
Timo WeideValery V Fokin

Abstract

Metallo-ß-lactamases (MBL) are an emerging cause of bacterial resistance to antibiotic treatment. The VIM-2 ß-lactamase is the most commonly encountered MBL in clinical isolates worldwide. Described here are potent and selective small molecule inhibitors of VIM-2 containing the arylsulfonyl-NH-1,2,3-triazole chemotype that potentiate the efficacy of the ß-lactam, imipenem, in E. coli.

References

Feb 4, 2003·The Journal of Antimicrobial Chemotherapy·Jean-Denis DocquierGian Maria Rossolini
Jul 9, 2003·Annals of Medicine·David M Livermore
Jan 28, 2005·The New England Journal of Medicine·George A Jacoby, Luisa Silvia Munoz-Price
Apr 16, 2005·Clinical Microbiology Reviews·Timothy R WalshPatrice Nordmann
Dec 28, 2005·Bioorganic & Medicinal Chemistry·Lars OlsenFlemming S Jørgensen
Jan 16, 2007·International Journal of Antimicrobial Agents·Giuseppe CornagliaUNKNOWN ESCMID Study Group for Antimicrobial Resistance Surveillance (ESGARS)
Oct 4, 2008·BMC Evolutionary Biology·Marjorie A LiénardChrister Löfstedt
Jun 26, 2009·Bioorganic & Medicinal Chemistry·Dmitriy MinondPeter Hodder

❮ Previous
Next ❯

Citations

Jul 19, 2013·Future Medicinal Chemistry·Dustin T King, Natalie C J Strynadka
Jan 8, 2013·Expert Opinion on Therapeutic Patents·Vitor F FerreiraJorge L Magalhães
Feb 4, 2014·European Journal of Medicinal Chemistry·Daniel GonzagaFloriano Paes Silva
Jun 25, 2016·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Zhen LiangChun Guo
Jun 30, 2016·Chemical Communications : Chem Comm·Joice ThomasWim Dehaen
Aug 24, 2011·Antimicrobial Agents and Chemotherapy·Krisztina M Papp-WallaceRobert A Bonomo
Oct 26, 2018·Organic & Biomolecular Chemistry·Huanhong WangWanzhi Chen
Apr 11, 2019·Organic & Biomolecular Chemistry·Angela S Carlson, Joseph J Topczewski
Nov 28, 2019·Dalton Transactions : an International Journal of Inorganic Chemistry·Ge MuThomas S Teets
Aug 31, 2019·Organic & Biomolecular Chemistry·Megan D HopkinsAngus A Lamar
Oct 25, 2017·Chemical Biology & Drug Design·Amaroju SureshKondapalli Venkata Gowri Chandra Sekhar
Apr 3, 2019·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Yilin ZhangKewu Yang
Feb 4, 2015·Chemical Biology & Drug Design·Rangappa S KeriBhari Mallanna Nagaraja
Dec 28, 2019·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Chen YuanLingling Yang
May 16, 2017·ChemMedChem·Laurent SevailleJean-François Hernandez
Apr 3, 2021·Organic Letters·Juliana R AlexanderJoseph J Topczewski
Apr 24, 2021·Chemical Communications : Chem Comm·J R AlexanderJ J Topczewski
Jun 8, 2021·RSC Chemical Biology·Adam L BorneKu-Lung Hsu
Aug 1, 2013·Journal of Medicinal Chemistry·Sander S van BerkelChristopher J Schofield
Sep 5, 2013·Organic Letters·Elif Akin KazanciogluRamazan Altundas
Dec 17, 2016·The Journal of Organic Chemistry·Sampad JanaWim Dehaen
Jan 17, 2020·The Journal of Organic Chemistry·Juliana R AlexanderJoseph J Topczewski

❮ Previous
Next ❯

Related Concepts

Related Feeds

Carbapenems

Carbapenems are members of the beta lactam class of antibiotics and are used for the treatment of severe or high-risk bacterial infections. Discover the latest research on carbapenems here.

Carbapenems (ASM)

Carbapenems are members of the beta lactam class of antibiotics and are used for the treatment of severe or high-risk bacterial infections. Discover the latest research on carbapenems here.